TERN

Terns Pharmaceuticals, Inc.

Pharmaceutical PreparationsNasdaq<br>Emerging growth company

Total Trades

Buys

Sells

Largest Trade

N/A

Insiders

Institutional Funds

174

Inst. Value

$1M+

Activist Filings

Insider Trades

Insider	Title	Type	Value	Shares	Price	Date
Burroughs Amy L.	CEO	GRANT	N/A	150K	—	Jan 16, 2026
Burroughs Amy L.	CEO	SELL	$1M+	69K	$37.07	Jan 16, 2026
Burroughs Amy L.	CEO	EXERCISE	$100K–$500K	69K	$4.64	Jan 16, 2026
Burroughs Amy L.	CEO	SELL	$1M+	71K	$38.10	Jan 7, 2026
Burroughs Amy L.	CEO	EXERCISE	$50K–$100K	172K	$0.58	Jan 7, 2026
Kuriakose Emil	Chief Medical Offi…	SELL	$15K–$50K	1K	$38.57	Jan 7, 2026
Quigley Jill M.	Director	SELL	$100K–$500K	25K	$18.00	Nov 5, 2025
Quigley Jill M.	Director	EXERCISE	$100K–$500K	25K	$9.24	Nov 5, 2025
Kuriakose Emil	Chief Medical Offi…	SELL	$1K–$15K	944	$7.85	Oct 2, 2025
Kuriakose Emil	Chief Medical Offi…	SELL	$1K–$15K	853	$4.27	Jul 3, 2025
Gengos Andrew	CFO	BUY	$15K–$50K	10K	$3.93	Jun 30, 2025
Burroughs Amy L.	CEO	BUY	$50K–$100K	23K	$3.87	Jun 25, 2025
Gengos Andrew	CFO	BUY	$50K–$100K	15K	$3.81	Jun 16, 2025
Kuriakose Emil	Chief Medical Offi…	SELL	$1K–$15K	952	$2.49	Apr 2, 2025
Kuriakose Emil	Chief Medical Offi…	SELL	$15K–$50K	4K	$5.71	Jan 7, 2025
Vignola Mark J.	CFO	SELL	$50K–$100K	17K	$5.76	Jan 7, 2025
Quigley Jill M.	Director	SELL	$50K–$100K	15K	$5.76	Jan 7, 2025
Yoon Seokho Bryan	COO and General Co…	BUY	$15K–$50K	5K	$4.44	Jun 4, 2024
Vignola Mark J.	CFO	BUY	$15K–$50K	5K	$4.44	Jun 4, 2024
Vivo Opportunity, LLC	10% Owner	SELL	$1M+	421K	$6.65	Apr 4, 2024
Yoon Seokho Bryan	COO and General Co…	BUY	$1K–$15K	743	$3.78	Dec 4, 2023
Vignola Mark J.	CFO	BUY	$1K–$15K	743	$3.78	Dec 4, 2023
Vignola Mark J.	CFO	BUY	$1K–$15K	10K	$1.41	Jun 2, 2023
Yoon Seokho Bryan	COO and General Co…	BUY	$1K–$15K	10K	$1.41	Jun 2, 2023
Sundaram Senthil Vel	CEO	BUY	$1K–$15K	2K	$1.41	Jun 2, 2023
Yoon Seokho Bryan	COO and General Co…	BUY	<$1K	3	$1.41	Feb 3, 2023
Vignola Mark J.	CFO	BUY	<$1K	3	$1.41	Feb 3, 2023
Sundaram Senthil Vel	CEO	BUY	<$1K	3	$1.41	Feb 3, 2023
ORBIMED ADVISORS LLC	Director	BUY	$500K+	138K	$7.25	Dec 28, 2022
GORDON CARL L	Director	BUY	$500K+	138K	$7.25	Dec 28, 2022
Vivo Opportunity, LLC	10% Owner	BUY	$1M+	759K	$7.25	Dec 23, 2022
Lu Hongbo	Director	BUY	$1M+	759K	$7.25	Dec 23, 2022
LAV Biosciences Fund V, L.P.	10% Owner	SELL	$1M+	1.5M	$5.50	Nov 28, 2022
Vivo Opportunity, LLC	10% Owner	BUY	$1M+	600K	$3.60	Sep 9, 2022
Lu Hongbo	Director	BUY	$1M+	600K	$3.60	Sep 9, 2022
ORBIMED ADVISORS LLC	Director	BUY	$1M+	3.7M	$2.42	Aug 18, 2022
GORDON CARL L	Director	BUY	$1M+	3.7M	$2.42	Aug 18, 2022
Vivo Opportunity, LLC	10% Owner	BUY	$1M+	2.6M	$2.66	Aug 17, 2022
Lu Hongbo	Director	BUY	$1M+	2.6M	$2.66	Aug 17, 2022
Yoon Seokho Bryan	COO and General Co…	BUY	$1K–$15K	8K	$1.47	Jun 9, 2022
Vignola Mark J.	CFO	BUY	$1K–$15K	8K	$1.47	Jun 9, 2022
Sundaram Senthil Vel	CEO	BUY	$1K–$15K	8K	$1.47	Jun 9, 2022

🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 174 funds holding

Fund	Shares	Value	Type
Vivo Capital, LLC	5.3M	$1M+	SH
VANGUARD GROUP INC	4.9M	$1M+	SH
Capitolis Liquid Global Markets LLC	3.0M	$1M+	SH
LORD, ABBETT & CO. LLC	2.7M	$1M+	SH
ORBIMED ADVISORS LLC	2.2M	$1M+	SH
GEODE CAPITAL MANAGEMENT, LLC	1.8M	$1M+	SH
STATE STREET CORP	1.8M	$1M+	SH
Ikarian Capital, LLC	1.6M	$1M+	SH
Pictet Asset Management Holding SA	1.6M	$1M+	SH
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	1.5M	$1M+	SH
TORONTO DOMINION BANK	1.4M	$1M+	SH
ALLIANCEBERNSTEIN L.P.	1.3M	$1M+	SH
Candriam S.C.A.	1.3M	$1M+	SH
DIMENSIONAL FUND ADVISORS LP	1.2M	$1M+	SH
Capital International Investors	1.1M	$1M+	SH
BALYASNY ASSET MANAGEMENT L.P.	892K	$1M+	SH
First Turn Management, LLC	872K	$1M+	SH
Deep Track Capital, LP	769K	$1M+	SH
Schonfeld Strategic Advisors LLC	754K	$1M+	SH
Logos Global Management LP	750K	$1M+	SH